Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Guanfacine

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,937Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Wanbang Biopharms Generic Guanfacine Hydrochloride Receives Approval in US
    Wanbang Biopharms Generic Guanfacine Hydrochloride Receives Approval in US

    12 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217638

    FDA
    12 Jun 2024
    Share Share
    Xiromed`s Generic Guanfacine Hydrochloride Receives Approval in the U.S.
    Xiromed`s Generic Guanfacine Hydrochloride Receives Approval in the U.S.

    23 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218326

    FDA
    23 Feb 2024
    Share Share
    Health Canada Issues Recall of JAMP Guanfacine XR 1 mg: Foreign tablets
    Health Canada Issues Recall of JAMP Guanfacine XR 1 mg: Foreign tablets

    14 Dec 2023

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/jamp-guanfacine-xr-1-mg-foreign-tablets

    HEALTH CANADA
    14 Dec 2023
    Share Share
    Alembic's Generic Guanfacine Hydrochloride Receives Approval in the U.S.
    Alembic's Generic Guanfacine Hydrochloride Receives Approval in the U.S.

    07 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217269

    FDA
    07 Aug 2023
    Share Share
    TWI Pharms`s Generic Guanfacine Hydrochloride Receives Approval in the US
    TWI Pharms`s Generic Guanfacine Hydrochloride Receives Approval in the US

    08 Jun 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216399

    FDA
    08 Jun 2022
    Share Share
    Apotex Corp. Issues Voluntary Nationwide Recall of Guanfacine Extended
    Apotex Corp. Issues Voluntary Nationwide Recall of Guanfacine Extended

    31 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/apotex-corp-issues-voluntary-nationwide-recall-of-guanfacine-extended-release-tablets-2mg-due-to-trace-amounts-of-quetiapine-fumarate-301259956.html

    PRNEWSWIRE
    31 Mar 2021
    Share Share